A Study to Evaluate the Safety and Tolerability of Intravenous Stemis™ in Elderly Subjects With Mild to Moderate Frailty Syndrome

NCT07462819 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Frailty Syndrome

Interventions

BIOLOGICAL: Stemis™
DRUG: Normal Saline

Sponsor

Ji Yan Biomedical Co., Ltd.

Collaborators

[object Object]